BioSpace News Archive

Applied Extracts Inc., a California-based manufacturer of scientific instruments, is announcing that the company is in the process of developing a novel environmentally friendly sterilization technology with broad potential applications including mitigating the spread of the Coronavirus and other pathogens.

SpendEdge, a global procurement market intelligence firm, has announced the availability of its Global Bioinformatics and Exploratory Data Analysis Market Procurement Intelligence Report for preorder.

Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand for ventilators, extra corporeal life support equipment and advanced monitoring for Intensive Care Units.

MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it has received regulatory approval to market and sell its SIAscopy on DermSecure TM skin assessment platform in Brazil.

Sartorius Stedim Biotech S.A. will postpone its Annual General Shareholders’ Meeting formerly scheduled for March 24, 2020, to a later date due to the coronavirus pandemic and the associated restrictions imposed on travel and meetings.

Abivax SA (Euronext Paris: FR0012333284 – ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today announced its 2019 yearly financial results, as of December 31, 2019, and provided an update on progress in its product pipeline.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City Health and Hospital Corporation (NYC Health + Hospitals) to provide coronavirus disease 2019 (COVID-19) testing

Evonik announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials.

Maravai LifeSciences, a global provider of life science reagents and services to researchers and biotech partners, announced that it has acquired MockV Solutions.

Aurinia Pharmaceuticals Inc. announced that the Company has established its U.S. commercial center of operations in Rockville, Maryland.